Sermorelin/GHRP-6 recall: Sterility Concern
Sermorelin/GHRP-6, 3 mg/3 mg, 5 mL vial, Stock # 21740, Compounded by NuVision Pharmacy, Dallas, TX 75244
Why was Sermorelin/GHRP-6 recalled?
Lack of Assurance of Sterility: The recall is being initiated due to a lack of sterility assurance and concerns associated with the quality control processes identified during an FDA inspection.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #:N10172012@11, Exp 10/17/2013
- Product
- Sermorelin/GHRP-6, 3 mg/3 mg, 5 mL vial, Stock # 21740, Compounded by NuVision Pharmacy, Dallas, TX 75244
- Recalling firm
- NuVision Pharmacy, Inc.
- Quantity
- 122 vials
- Distribution
- Nationwide
- Recall date
- February 5, 2014
- Classification
- Class I
- Status
- Terminated
- Agency
- FDA (drug)